FT113
FT113 is a potent and orally active fatty acid synthase (FASN) inhibitor, with an IC50 of 213 nM for full-length recombinant human FASN enzyme. In cell-based assay, FT113 blocks FASN activity in BT474 cells (IC50, 90 nM) . FT113 shows anti-proliferative activity, and exhibits anti-cancer activity both in vitro and in vivo[1].
Product Specifications
CAS Number
1630808-89-7
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Fatty Acid Synthase (FASN)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/FT113.html
Purity
99.39
Solubility
DMSO : 62.5 mg/mL (ultrasonic)
Smiles
O=C(C1(CC1)O)N2CCN(C(C3=CC=C(C4=NC5=C(C=C(F)C=C5)O4)C=C3)=O)CC2
Molecular Formula
C22H20FN3O4
Molecular Weight
409.41
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
MIA2 (Melanoma Inhibitory Activity 2, FLJ22404) (Biotin)
MIA2 (Melanoma Inhibitory Activity 2, FLJ22404) (Biotin)
Polyclonal Antibody to Plasminogen Activator, Urokinase (uPA)
Polyclonal Antibody to Plasminogen Activator, Urokinase (uPA)
Polyclonal Antibody to Plasminogen Activator, Urokinase (uPA)